Eddine Saiah

Eddine Saiah

Company: Stablix

Job title: Chief Scientific Officer


Harnessing Deubiquitinases (DUBs) as a Novel Therapeutic Modality 8:30 am

Identifying high impact targets for targeted deubiquitination therapeutics (TDT) Deploying novel ligands for DUB recruitment Novel insights into TDT and RESTORAC developmentRead more

day: Post-Conference Focus Day: Next Generation TPD

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.